redness at injection site tirzepatide Injection site reaction : r/tirzepatidecompound

Patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, uncontrolled diabetes, or severe renal impairment should not use GLP-1 medications

While not FDA-approved as a combination, some providers may prescribe these medications together to break plateaus

Monitor your patients carefully

Use Sterile Needles Every Time : Always use a new, sterile needle each time you draw medication from the vial

PHD activates the pseudohypoxic response by stabilizing HIF-1, which is a well-known tumorigenesis enhancer, and as a transcription factor, maintains the metabolic reprogramming of cancer cells to support their survival 127